Kazazian Asset Management’s GSK GSK Stock Holding History

Kazazian Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,024	Closed	-$503K	–	71
2018 Q3	$503K	Hold	10,024	–	–	0.47%	46
2018 Q2	$505K	Sell	10,024 -385	-4%	-$19.4K	0.46%	44
2018 Q1	$508K	Hold	10,409	–	–	0.53%	42
2017 Q4	$462K	Buy	10,409 +1,079	+12%	+$49.8K	0.47%	49
2017 Q3	$473K	Buy	9,330 +3,850	+70%	+$195K	0.58%	39
2017 Q2	$295K	Buy	+5,480	New	+$292K	0.45%	41
2016 Q1	–	Sell	-11,566	Closed	-$583K	–	65
2015 Q4	$583K	Sell	11,566 -15,114	-57%	-$770K	0.78%	19
2015 Q3	$1.28M	Buy	+26,680	New	+$1.39M	1.62%	15
2015 Q2	–	Sell	-14,186	Closed	-$818K	–	101
2015 Q1	$818K	Sell	14,186 -7,966	-36%	-$457K	1.07%	22
2014 Q4	$1.18M	Buy	+22,152	New	+$1.24M	1.03%	22

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Kazazian Asset Management's GSK Position: Q4 2018 in Review

Kazazian Asset Management sold out of GSK (GSK) in Q4 2018, closing a stake of 10,024 shares — an estimated $503K sold.

Kazazian Asset Management first reported a position in GSK in Q4 2014 and held it in 10 quarters. The position peaked at $1.28M in Q3 2015. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Kazazian Asset Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Kazazian Asset Management sold 10,024 GSK shares in Q4 2018, an estimated $503K.
Kazazian Asset Management first reported a position in GSK in Q4 2014 and held it in 10 quarters.
Kazazian Asset Management's GSK position peaked at $1.28M in Q3 2015.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Kazazian Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.